Efficacy of Nasal High Flow therapy on the coordination between breathing and swallowing of saliva during daytime nap in COPD patients. A single center, randomized crossover controlled study.

Ayuse Takao0 个研究点目标入组 15 人开始时间: 2020年5月21日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•The severity of COPD is moderate (GOLD2) or more.
•Age: At the time of obtaining consent, an adult patient 40 years or older
•Gender: Any
•Hospitalization / Outpatient: Outpatient only
•Patients who have been given sufficient explanations to participate in this study and have given their full understanding and informed consent from the patient

•Patients who cannot breathe nose
•Patients with a history of pneumothorax
•Patients with active malignancy
•Patients with acute disease (such as acute myocardial infarction)
•Patients currently diagnosed with asthma (Patients who have a history of asthma but are currently diagnosed with COPD are eligible for inclusion.)
•Patients who have been diagnosed with obstructive sleep apnea in the past and who are strongly suspected clinically
•Patients already using NHF
•Patients who are using non-invasive ventilation (NIV) at night
•Patients with severe disease of the kidney, liver or circulatory system
•Patients who are considered inappropriate by the Principal Investigator
•Patients who are positive for the new coronavirus (SARS-CoV-2) PCR test

发起方

Ayuse Takao